Search
for
Sort by
Research 691–720 of 1000+
- 1,314
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
- Phenyl Propanoid 1’s-1′-Acetoxychavicol Acetate Protects Against Testosterone-Induced Alopecia by Inhibiting Nadph Oxidase
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Long-Term Effects of COVID-19
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- The role of WNT10B in physiology and disease: A 10-year update
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Genetic variation in the ovine <i>KAP22-1</i> gene and its effect on wool traits in Egyptian sheep
- Unveiling Post-COVID-19 syndrome: incidence, biomarkers, and clinical phenotypes in a Thai population
- Association of Polycystic Ovary Syndrome (PCOS) with Acne Vulgaris: An observational&nbsp;<span style="font-size: 1rem;">study</span>
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Peculiarities of long-COVID-19 and treatment strategy: a clinical case
- Referee report. For: Autologous stromal vascular fraction cells combined with platelet-rich plasma for androgenic alopecia treatment: a case series [version 1; peer review: 2 approved with reservations]
- Referee report. For: Autologous stromal vascular fraction cells combined with platelet-rich plasma for androgenic alopecia treatment: a case series [version 1; peer review: 1 approved with reservations]
- Referee report. For: Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review [version 1; peer review: 2 approved with reservations]
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- Molecular biology of hair morphogenesis: Development and cycling
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes